Skip to content

Clinical trials

Shock, Septic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Septic Country / region: South Korea Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20092
20111
20121
20132
20181
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Terminated2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center2
Eisai Inc.1
Gil Joon Suh1
GlaxoSmithKline1
Green Cross Corporation1
Samsung Medical Center1
Seoul National University Bundang Hospital1
Seoul National University Hospital1
Tae Gun Shin1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Septic11
Sepsis9
Acute Kidney Injury1
Diabetes Insipidus1
Hypotension1
Multiple Organ Failure1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.